NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE242206 Query DataSets for GSE242206
Status Public on Oct 10, 2023
Title In Vivo Investigation of the Effect of Dietary Acrylamide and Evaluation of its Clinical Relevance in Colon Cancer
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Dietary exposure to Acrylamide (AA) has been linked with carcinogenicity in the gastrointestinal (GI) tract. However, epidemiologic data on AA intake in relation to cancer risk are limited and contradicting, while the potential cancer-inducing molecular pathways following AA exposure remain elusive. In this study, we collected mechanistic information regarding the induction of carcinogenesis by dietary AA in the colon, using an established animal model. Male Balb/c mice orally received AA (0.1 mg/kg/day) daily for 4 weeks. RNA was extracted from colon tissue samples, followed by RNA sequencing. Comparative transcriptomic analysis between AA and mock-treated groups revealed a set of differentially expressed genes (DEGs) that were further processed using different databases through the STRING-DB portal, to reveal deregulated protein-protein interaction networks. We found that genes implicated in RNA metabolism, processing and formation of the ribosomal subunits and protein translation and metabolism are upregulated in AA-exposed colon tissue; these genes were also overexpressed in human colon adenocarcinoma samples and were negatively correlated with patient overall survival (OS), based on publicly available datasets. Further investigation of the potential role of these genes during the early stages of colon carcinogenesis may shed light into the underlying mechanisms induced by dietary AA exposure.
 
Overall design To investigate the effects in colon gene expression patterns of dietary exposure to acrylamide in vivo using mouse models. Male Balb/c mice (n=5 per group) orally received AA (0.1 mg/kg/day) or PBS daily for 4 weeks. RNA was extracted from colon tissue samples, followed by RNA sequencing.
 
Contributor(s) Papageorgis P, Christodoulou M, Neophytou C
Citation(s) 37888706
Submission date Sep 01, 2023
Last update date Nov 09, 2023
Contact name Panagiotis Papageorgis
E-mail(s) p.papageorgis@euc.ac.cy
Organization name European University Cyprus
Department Life Sciences
Lab Tumor Microenvironment, Metastasis and Experimental Therapeutics
Street address 6 Diogenous street
City Egkomi
State/province Nicosia
ZIP/Postal code 02404
Country Cyprus
 
Platforms (1)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (9)
GSM7755015 PBS treatment - 1
GSM7755016 PBS treatment - 2
GSM7755017 PBS treatment - 3
Relations
BioProject PRJNA1011983

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE242206_Galaxy51-_DESeq2_result_files_on_data_43__data_39__and_others_Treatment_PBS_vs_Acr_.xlsx 3.3 Mb (ftp)(http) XLSX
GSE242206_RAW.tar 1.9 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap